Loading...
XKRX
006280
Market cap913mUSD
Jul 10, Last price  
123,200.00KRW
1D
2.16%
1Q
-14.62%
Jan 2017
-21.53%
Name

Green Cross Corp

Chart & Performance

D1W1MN
XKRX:006280 chart
P/E
—
P/S
0.71
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
5.77%
Revenues
1.99t
+18.54%
442,299,046,000516,096,685,000643,208,349,000791,015,317,000767,911,770,550811,774,313,000888,168,207,110975,327,105,7301,047,812,247,3301,197,903,918,4001,287,916,286,2201,334,877,810,1101,369,709,727,0001,504,115,279,0001,537,825,750,0001,711,312,740,0001,626,643,816,0001,679,891,941,0001,991,279,094,000
Net income
-4.67b
L-82.22%
44,357,145,00048,872,734,00080,524,433,000104,688,642,00055,367,168,00053,643,053,42070,066,278,51083,944,674,44094,967,401,93062,969,546,58053,246,604,74034,429,474,380-11,287,400,00081,048,858,000123,211,806,00065,453,134,000-26,631,783,000-26,280,215,000-4,673,833,000
CFO
99.46b
P
35,223,947,000-20,729,139,000112,006,156,00084,471,459,00054,855,488,03050,756,715,57029,689,475,48056,763,005,92045,243,777,660-1,742,284,53057,879,006,00014,410,216,14040,291,382,00035,973,501,000125,978,949,000119,154,311,000-5,472,810,000-53,460,079,00099,462,778,000
Dividend
Dec 27, 20241500 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.
URL
http://gcbiopharma.com/
IPO date
Aug 01, 1989
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT